Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert S. Aronstam is active.

Publication


Featured researches published by Robert S. Aronstam.


Toxicology and Applied Pharmacology | 1979

Transition and heavy metal inhibition of ligand binding to muscarinic acetylcholine receptors from rat brain.

Robert S. Aronstam; Mohyee E. Eldefrawi

Several divalent heavy metals interact with muscarinic acetylcholine receptors in neural membranes from rat forebrains in vitro to inhibit the the binding of [3H]3-quinuclidinyl benzilate (QNB), a potent and specific receptor antagonist. Mercury is the most potent inhibitor with an ID50 value of 10−7 m for the inhibition of the binding of 10−10 m QNB. Several other metals are less effective with ID50 values between 10−5 and 2 × 10−4 m increasing in the following order: iron 10−3 m). Binding inhibition by copper, mercury, and cadmium is competitive, and the inhibition by all the metals can be reversed by decreasing the free metal concentration through dilution or chelation by ethylenediaminetetraacetate, dimercaprol, or penicillamine. The effects of metals on muscarinic binding are largely independent of temperature. Chaotropic anions (100 mm iodide, thiocyanate, trichloroacetate, or nitrate) are similarly without effect on the metal-receptor interaction. The limited effects of sulfhydryl reducing (dithiothreitol, 2-mercaptoethanol, and glutathione) and alkylating (N-ethyl maleimide) reagents do not indicate a prominent role for sulfhydryl groups in mediating metal inhibition of muscarinic receptors.


Journal of Pharmacology and Experimental Therapeutics | 1990

The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels.

A. S. Ramoa; Manickavasagom Alkondon; Yasco Aracava; J Irons; G. Lunt; Sharad S. Deshpande; Susan Wonnacott; Robert S. Aronstam; E X Albuquerque


Molecular Pharmacology | 1986

Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a.

K L Swanson; C N Allen; Robert S. Aronstam; Rapoport H; E X Albuquerque


Molecular Pharmacology | 1980

Sites of action of phencyclidine. II. Interaction with the ionic channel of the nicotinic receptor.

Edson X. Albuquerque; Ming-Cheng Tsai; Robert S. Aronstam; Amira T. Eldefrawi; Mohyee E. Eldefrawi


Journal of Biological Chemistry | 1981

Regulation of [3H]perhydrohistrionicotoxin binding to Torpedo ocellata electroplax by effectors of the acetylcholine receptor.

Robert S. Aronstam; Amira T. Eldefrawi; I N Pessah; John W. Daly; E X Albuquerque; M E Eldefrawi


Molecular Pharmacology | 1980

Sites of Action of Phencyclidine: III. Interactions with Muscarinic Receptors

Robert S. Aronstam; Mohyee E. Eldefrawi; Amira T. Eldefrawi; Edson X. Albuquerque; Kam F. Jim; David J. Triggle


Molecular Pharmacology | 1980

Sites of action of phencyclidine. I. Effects on the electrical excitability and chemosensitive properties of the neuromuscular junction of skeletal muscle.

Ming-Cheng Tsai; Edson X. Albuquerque; Robert S. Aronstam; Amira T. Eldefrawi; Mohyee E. Eldefrawi; David J. Triggle


Journal of Pharmacology and Experimental Therapeutics | 1991

Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites.

K L Swanson; Robert S. Aronstam; Susan Wonnacott; H Rapoport; E X Albuquerque


Biochemical Pharmacology | 1979

Reversible conversion between affinity states for agonists of the muscarinic acetylcholine receptor from rat brain

Robert S. Aronstam; Mohyee E. Eldefrawi


Molecular Pharmacology | 1984

Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.

Stephen R. Ikeda; Robert S. Aronstam; John W. Daly; Yasco Aracava; E X Albuquerque

Collaboration


Dive into the Robert S. Aronstam's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

K L Swanson

University of Maryland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John W. Daly

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge